Profile picture of Reuters
Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return: An experimental mRNA cancer vaccine developed by Moderna Inc (MRNA.O) and Merck & Co (MRK ...
reuters.com/business/healthcare-pharmaceuticals/moderna-cancer-vaccine-with-mercks-keytruda-delays-return-deadly-skin-cancer-2023-04-16/
Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return
Profile picture of Investor's Business Daily
Merck Snags $10.8 Billion Buyout As Keytruda Declines Loom: Merck is acquiring Prometheus Bio in a well-timed $10.8 billion deal ahead of Keytruda's patent loss ...
investors.com/news/technology/rxdx-stock-merck-nabs-deal-as-keytruda-patent-expiration-looms/
Merck Snags $10.8 Billion Buyout As Keytruda Declines Loom
Profile picture of Reuters
Merck, Eisai to discontinue late-stage study for skin cancer: Merck & Co Inc (MRK.N) and Eisai Co Ltd (4523.T) said on Friday they were discontinuing a ...
reuters.com/business/healthcare-pharmaceuticals/merck-eisai-discontinue-late-stage-study-skin-cancer-2023-04-07/
Merck, Eisai to discontinue late-stage study for skin cancer
Profile picture of Investor's Business Daily
Moderna Crumbles On The 'Longish' Road For Its Cancer Vaccine: Moderna stock crumbled Monday after updated results for its Merck-partnered cancer vaccine show a ...
investors.com/news/technology/moderna-stock-crumbles-on-longish-road-for-cancer-vaccine/
Moderna Crumbles On The 'Longish' Road For Its Cancer Vaccine
Profile picture of Investor's Business Daily
Moderna Stumbles Despite A Win For Its Cancer Vaccine: Moderna stock fell Monday after European regulators granted its Merck-partnered personalized cancer ...
investors.com/news/technology/moderna-stock-jumps-on-european-designation-for-cancer-vaccine/
Moderna Stumbles Despite A Win For Its Cancer Vaccine
Profile picture of Reuters
Merck scraps third prostate cancer study as Keytruda therapy disappoints: Merck & Co (MRK.N) on Tuesday scrapped a late-stage trial of a combination therapy with ...
reuters.com/business/healthcare-pharmaceuticals/merck-discontinue-keytruda-combination-study-prostate-cancer-2023-02-28/
Merck scraps third prostate cancer study as Keytruda therapy disappoints
Profile picture of Investor's Business Daily
Could Merck's Next Keytruda-Like Drugs Top $10 Billion In Sales?: Two of Merck's new drugs could generate north of $10 billion in peak sales ...
investors.com/news/technology/merck-stock-keytruda-who-analysts-eye-two-heart-drugs/
Could Merck's Next Keytruda-Like Drugs Top $10 Billion In Sales?
Profile picture of Reuters
Senator Warren urges U.S. patent office to scrutinize Merck's Keytruda: U.S. Senator Elizabeth Warren sent the nation's top patent regulator a letter urging ...
reuters.com/world/us/senator-warren-urges-us-patent-office-scrutinize-mercks-keytruda-2023-02-23/
Senator Warren urges U.S. patent office to scrutinize Merck's Keytruda
Profile picture of The Hill (newspaper)
Moderna mRNA vaccine reduced risk of skin cancer relapse: research: Researchers found the combination of Moderna’s mRNA vaccine and Merck’s Keytruda in melanoma ...
thehill.com/policy/healthcare/3773428-moderna-mrna-vaccine-reduced-risk-of-skin-cancer-relapse-research/
Moderna mRNA vaccine reduced risk of skin cancer relapse: research
Profile picture of Radio New Zealand
Pharmac set to fund two sought-after lung cancer drugs, Keytruda and Tecentriq: Pharmac has reached provisional agreements with the markers of Keytruda and ...
rnz.co.nz/news/national/480884/pharmac-set-to-fund-two-sought-after-lung-cancer-drugs-keytruda-and-tecentriq
Pharmac set to fund two sought-after lung cancer drugs, Keytruda and ...
Profile picture of Reuters
Profile picture of Yahoo Finance

Moderna CEO Stéphane Bancel discusses a breakthrough in trials for a personalized cancer vaccine being jointly produced with pharmaceutical company Merck ... Show more

Profile picture of ExtremeTech
Scientists Are Testing a Personalized Skin Cancer Vaccine - ExtremeTech: The vaccine combines two medical technologies: the mRNA vaccine and Keytruda ...
extremetech.com/extreme/340286-scientists-are-testing-a-personalized-skin-cancer-vaccine
Scientists Are Testing a Personalized Skin Cancer Vaccine - ExtremeTech